non-immunogenic staphylokinase

DRUG2 trials

Sponsors

Supergene, LLC

Conditions

Acute Ischemic StrokeIschemic Stroke, Acute

Phase 3

Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset

RecruitingNCT07324837

Supergene, LLCIschemic Stroke, Acute

Start: 2026-06-09End: 2029-01-01Target: 990Updated: 2026-07-23

Unknown Phase

Post-registration Trial of the Non-immunogenic Staphylokinase in Acute Ischemic Stroke (FORPI Registry)

CompletedNCT06707987

Supergene, LLCAcute Ischemic Stroke

Start: 2021-03-01End: 2025-02-01Updated: 2025-12-05

Related Papers

Thrombolysis With the Non-Immunogenic Staphylokinase for Acute Ischemic Stroke in the FORPI Registry: An Observational Study.

2025-11-261 citations